Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:09 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure
NCT01005290 · Ferrer Internacional S.A. · PHASE2 · terminated · last registry update 2012-07-26 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Ferrer Internacional S.A. |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ACE within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2012-07-26Also stopped (terminated): Assistance Publique - Hôpitaux de Paris, Enalapril + Placebo (NCT01096121)
- 2012-06-18Results posted on the registry: AstraZeneca, Captopril + Enalapril (NCT00391846)
- 2012-06-01Results posted on the registry: NHS Greater Glasgow and Clyde, ACE inhibitor - ramipril, enalapril, captopril, perindopril, lisinopril + Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol (NCT00292162)
- 2012-05-11Results posted on the registry: Vanderbilt University, Placebo + Enalapril 5mg (NCT00666848)
- 2012-04-23Phase 3 first posted: Institut National de la Santé Et de la Recherche Médicale, France, perindopril + placebo (NCT01583114)
- 2012-04-20Phase 3 first posted: University of Cambridge, Statin + ACE inhibitor (NCT01581476)
- 2012-03-30Results posted on the registry: Charles Drew University of Medicine and Science, benazepril + benazepril (NCT00907374)
- 2012-03-19Phase 3 first posted: Symplmed Pharmaceuticals LLC, XOMA 985 + Amlodipine Besylate (NCT01556997)
- 2011-09-20Phase 3 first posted: University Hospital, Clermont-Ferrand, - Angiotensin conversing enzyme inhibitors: enalapril, captopril, lisinopril, ramipril, trandolapril. (NCT01437371)
- 2011-08-30Also stopped (terminated): University Hospital, Strasbourg, France, Pravastatin, Carvedilol, Perindopril (NCT00402376)
- 2011-08-24Phase 3 first posted: The George Institute, Low-dose rtPA + Standard-dose rtPA (NCT01422616)
- 2011-08-08Phase 3 first posted: Wake Forest University, Enalapril + placebo (NCT01411735)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision